lobbying_activities: 2889107

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2889107	d1a794b8-cdad-4492-bd1e-cf88dfa7daeb	Q3	CAPITOL HILL CONSULTING GROUP	72053	PURDUE PHARMA LLP	2022	third_quarter	BNK	Monitored congressional efforts around the SACKLER Act, including H.R. 2096 / S. 2472 and HR 4777 / S 2497, including outreach regarding potential committee activity on the legislation.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2022-10-20T13:36:01-04:00